Ilan Oren
Known title: DirectorCIK: 0001643073
Associated companies
Transaction History
| ROIV | ▲ Buy | Grant | 5,054 | $0 | 9/16/2026 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 2,378 | $97K | 9/10/2026 | View on chart |
| ROIV | ▲ Buy | Grant | 775 | $0 | 7/17/2026 | View on chart |
| ROIV | ▲ Buy | Grant | 896 | $0 | 4/17/2026 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 95 | $3K | 4/17/2026 | View on chart |
| ROIV | ▲ Buy | Grant | 1,164 | $0 | 1/20/2026 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 124 | $3K | 1/20/2026 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 281 | $5K | 10/20/2025 | View on chart |
| ROIV | ▲ Buy | Grant | 1,507 | $0 | 10/20/2025 | View on chart |
| ROIV | ▲ Buy | Grant | 14,524 | $0 | 9/10/2025 | View on chart |
| ROIV | ▼ Sell | Other | 2,043 | $28K | 9/10/2025 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 64 | $650 | 4/17/2025 | View on chart |
| ROIV | ▲ Buy | Grant | 2,296 | $0 | 4/17/2025 | View on chart |
| ROIV | ▲ Buy | Grant | 2,635 | $0 | 4/17/2025 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 115 | $1K | 4/17/2025 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 313 | $4K | 1/23/2025 | View on chart |
| ROIV | ▲ Buy | Grant | 2,386 | $0 | 1/23/2025 | View on chart |
| ROIV | ▲ Buy | Grant | 2,303 | $0 | 10/21/2024 | View on chart |
| ROIV | ▼ Sell | Other | 3,487 | $42K | 9/12/2024 | View on chart |
| ROIV | ▲ Buy | Grant | 16,406 | $0 | 9/10/2024 | View on chart |
| ROIV | ▲ Buy | Grant | 2,440 | $0 | 7/23/2024 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 215 | $2K | 7/23/2024 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 54 | $589 | 4/24/2024 | View on chart |
| ROIV | ▲ Buy | Grant | 2,121 | $0 | 4/24/2024 | View on chart |
| ROIV | ▲ Buy | Grant | 3,366 | $0 | 1/19/2024 | View on chart |
| ROIV | ▲ Buy | Grant | 2,269 | $0 | 10/16/2023 | View on chart |
| ROIV | ▼ Sell | Other | 8,703 | $97K | 9/18/2023 | View on chart |
| ROIV | ▲ Buy | Grant | 17,825 | $0 | 9/12/2023 | View on chart |
| ROIV | ▲ Buy | Grant | 1,472 | $0 | 7/3/2023 | View on chart |
| ROIV | ▲ Buy | Grant | 1,942 | $0 | 4/3/2023 | View on chart |
| ROIV | ▲ Buy | Grant | 2,010 | $0 | 1/3/2023 | View on chart |
| ROIV | ▲ Buy | Grant | 2,796 | $0 | 10/31/2022 | View on chart |
| ROIV | ▲ Buy | Grant | 52,142 | $0 | 9/15/2022 | View on chart |
| ROIV | ▲ Buy | Grant | 3,223 | $0 | 7/20/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Roivant Sciences receives downgrades from Wolfe Research and analyst
Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.
Roivant Sciences receives downgrades from Wolfe Research and analyst. Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.